WOODWARDS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 20 product registrations across 41 distinct molecules. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Anti-Infectives. DRAP has issued 4 alerts involving its products.
Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.
Products by WOODWARDS
2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.
This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.